Esperion Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

ANN ARBOR, Mich. (AP) — ANN ARBOR, Mich. (AP) — Esperion Therapeutics Inc. (ESPR) on Tuesday reported a loss of $56.3 million in its fourth quarter.

The Ann Arbor, Michigan-based company said it had a loss of 50 cents per share.

The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 53 cents per share.

The biopharmaceutical company posted revenue of $32.3 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $26.8 million.

For the year, the company reported a loss of $209.2 million, or $2.03 per share. Revenue was reported as $116.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR

Advertisement

Recommended Stories